Vaccine deals: India, Oxford-AstraZeneca numbers dip, but still on top; Pfizer gains most - Business News: Latest Share Market , Economy & Finance News | Trendmergers

Breaking

Post Top Ad

Post Top Ad

Vaccine deals: India, Oxford-AstraZeneca numbers dip, but still on top; Pfizer gains most

Analysis of contracts countries are signing with vaccine makers for advance booking of candidates shows that the deals are still fluid, changing in a matter of days with some companies gaining and some losing orders given that most candidates are still in trial stage.

from Industry-Economic Times
Read The Rest:economictimes...

Post Top Ad